| 1 | Abstract A053: A pre-operative Artificial Intelligence-based model to estimate the risk of cancer specific mortality in patients with non-metastatic kidney cancer | 6.8 | 0 | Citations (PDF) |
| 2 | Current training landscape for novice robotic surgeons: an international investigative survey by the Junior-ERUS/Young academic urologists (YAU) robotics in urology working group | 2.2 | 1 | Citations (PDF) |
| 3 | Letter: Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma | 4.2 | 1 | Citations (PDF) |
| 4 | Long-distance Robot-assisted Teleoperation: Every Millisecond Counts | 2.1 | 9 | Citations (PDF) |
| 5 | Case of the Month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses | 3.2 | 1 | Citations (PDF) |
| 6 | To clamp or not to clamp? A step back to go forward | 3.2 | 0 | Citations (PDF) |
| 7 | Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation | 3.5 | 26 | Citations (PDF) |
| 8 | Predicting Complications After Robotic Partial Nephrectomy: Back to Simplicity | 3.5 | 24 | Citations (PDF) |
| 9 | A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 | 1.8 | 38 | Citations (PDF) |
| 10 | Testosterone in males with COVID‐19: A 7‐month cohort study | 3.1 | 75 | Citations (PDF) |
| 11 | Simplified PADUA renal (SPARE) nephrometry score validation and long-term outcomes after robot-assisted partial nephrectomy | 1.8 | 15 | Citations (PDF) |
| 12 | Von Hippel–Lindau disease-associated renal cell carcinoma: a call to action | 2.0 | 13 | Citations (PDF) |
| 13 | The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy | 0.9 | 19 | Citations (PDF) |
| 14 | Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma | 1.8 | 38 | Citations (PDF) |
| 15 | Is Hypertension Associated with Worse Renal Functional Outcomes after Minimally Invasive Partial Nephrectomy? Results from a Multi-Institutional Cohort | 2.5 | 12 | Citations (PDF) |
| 16 | Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol. 2022;81:576–85. | 2.1 | 3 | Citations (PDF) |
| 17 | Prediction of significant renal function decline after open, laparoscopic, and robotic partial nephrectomy: External validation of the Martini’s nomogram on the RECORD2 project cohort | 1.7 | 19 | Citations (PDF) |
| 18 | Estimated Glomerular Filtration Rate Decline at 1 Year After Minimally Invasive Partial Nephrectomy: A Multimodel Comparison of Predictors | 0.6 | 42 | Citations (PDF) |
| 19 | Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma | 1.8 | 5 | Citations (PDF) |
| 20 | Multidisciplinary team referral at diagnosis for patients with non-metastatic renal cell carcinoma | 1.8 | 3 | Citations (PDF) |
| 21 | SIGIRR Downregulation and Interleukin-1 Signaling Intrinsic to Renal Cell Carcinoma | 2.6 | 4 | Citations (PDF) |
| 22 | Re: Caelán Max Haney, Maximilian C. Kriegmair, Maurice Stephan Michel, Jens-Uwe Stolzenburg, Karl-Friedrich Kowalewski. New Evidence and Innovative Approaches to Blinding in Robot-assisted Radical Cystectomy. Eur Urol. 2022;81:615–617 | 2.1 | 0 | Citations (PDF) |
| 23 | How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? | 2.2 | 7 | Citations (PDF) |
| 24 | Head to Head Impact of Margin, Ischemia, Complications, Score Versus a Novel Trifecta Score on Oncologic and Functional Outcomes After Robotic-assisted Partial Nephrectomy: Results of a Multicenter Series | 3.5 | 44 | Citations (PDF) |
| 25 | Robotic-assisted Partial Nephrectomy for “Very Small” (<2 cm) Renal Mass: Results of a Multicenter Contemporary Cohort | 3.5 | 13 | Citations (PDF) |
| 26 | Toward Individualized Approaches to Partial Nephrectomy: Assessing the Correlation Between Ischemia Time and Patient Health Status (RECORD2 Project) | 5.8 | 19 | Citations (PDF) |
| 27 | The Effect of Surgical Experience on Perioperative and Oncological Outcomes After Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Evidence from a Referral Centre with Extensive Experience in Robotic Surgery | 3.5 | 46 | Citations (PDF) |
| 28 | Technical Refinements in Superextended Robot-assisted Radical Prostatectomy for Locally Advanced Prostate Cancer Patients at Multiparametric Magnetic Resonance Imaging | 2.1 | 30 | Citations (PDF) |
| 29 | Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma | 0.9 | 16 | Citations (PDF) |
| 30 | How to Select the Optimal Candidates for Renal Mass Biopsy | 5.8 | 11 | Citations (PDF) |
| 31 | Outcomes of robot-assisted partial nephrectomy for completely endophytic renal tumors: A multicenter analysis | 0.9 | 56 | Citations (PDF) |
| 32 | The Impact of Surgical Strategy in Robot-assisted Partial Nephrectomy: Is It Beneficial to Treat Anterior Tumours with Transperitoneal Access and Posterior Tumours with Retroperitoneal Access? | 5.8 | 31 | Citations (PDF) |
| 33 | Re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.06.002 | 3.5 | 0 | Citations (PDF) |
| 34 | Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy | 3.5 | 5 | Citations (PDF) |
| 35 | Perioperative Outcomes of Open, Laparoscopic, and Robotic Partial Nephrectomy: A Prospective Multicenter Observational Study (The RECORd 2 Project) | 3.5 | 104 | Citations (PDF) |
| 36 | Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma | 2.2 | 48 | Citations (PDF) |
| 37 | Renal histology across the stages of chronic kidney disease | 1.5 | 13 | Citations (PDF) |
| 38 | Renal function outcomes in patients with muscle‐invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the PURE‐01 study | 4.3 | 8 | Citations (PDF) |
| 39 | How to improve outcome in nephron-sparing surgery: the impact of new techniques | 2.0 | 12 | Citations (PDF) |
| 40 | Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study | 11.4 | 159 | Citations (PDF) |
| 41 | Retroperitoneal versus transepritoneal robot-assisted partial nephrectomy for postero-lateral renal masses: an international multicenter analysis | 2.2 | 19 | Citations (PDF) |
| 42 | Salvage Robot-assisted Renal Surgery for Local Recurrence After Surgical Resection or Renal Mass Ablation: Classification, Techniques, and Clinical Outcomes | 2.1 | 23 | Citations (PDF) |
| 43 | High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? | 1.9 | 6 | Citations (PDF) |
| 44 | Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects | 2.5 | 17 | Citations (PDF) |
| 45 | The role of angioembolization in the management of blunt renal injuries: a systematic review | 1.5 | 29 | Citations (PDF) |
| 46 | Partial nephrectomy in frail patients: Benefits of robot-assisted surgery | 2.1 | 19 | Citations (PDF) |
| 47 | A virus-free cellular model recapitulates several features of severe COVID-19 | 3.4 | 5 | Citations (PDF) |
| 48 | The impact of sex and age on distribution of metastases in patients with renal cell carcinoma | 2.3 | 7 | Citations (PDF) |
| 49 | Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium | 2.2 | 14 | Citations (PDF) |
| 50 | Parenchymal biopsy in the management of patients with renal cancer | 2.2 | 16 | Citations (PDF) |
| 51 | Living Donor Robot-Assisted Kidney Transplantation: a New Standard of Care? | 2.4 | 4 | Citations (PDF) |
| 52 | Focus on Internal Urethrotomy as Primary Treatment for Untreated Bulbar Urethral Strictures: Results from a Multivariable Analysis | 3.5 | 33 | Citations (PDF) |
| 53 | Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old: Analysis of the REnal SURGery in Elderly (RESURGE) Group | 3.5 | 29 | Citations (PDF) |
| 54 | Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer | 5.8 | 51 | Citations (PDF) |
| 55 | Renal Function Loss After Cryoablation of Small Renal Masses in Solitary Kidneys: European Registry for Renal Cryoablation Multi-Institutional Study | 2.8 | 17 | Citations (PDF) |
| 56 | Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria | 1.4 | 32 | Citations (PDF) |
| 57 | The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery | 2.2 | 15 | Citations (PDF) |
| 58 | Transperitoneal vs retroperitoneal minimally invasive partial nephrectomy: comparison of perioperative outcomes and functional follow-up in a large multi-institutional cohort (The RECORD 2 Project) | 2.3 | 46 | Citations (PDF) |
| 59 | Technical and Functional Validation of a Teleoperated Multirobots Platform for Minimally Invasive Surgery | 2.6 | 14 | Citations (PDF) |
| 60 | Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma | 5.8 | 45 | Citations (PDF) |
| 61 | Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines | 2.1 | 37 | Citations (PDF) |
| 62 | Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis | 2.3 | 41 | Citations (PDF) |
| 63 | Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma | 1.8 | 16 | Citations (PDF) |
| 64 | Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset | 1.8 | 21 | Citations (PDF) |
| 65 | Effect of Obesity and Overweight Status on Complications and Survival After Minimally Invasive Kidney Surgery in Patients with Clinical T
2-4
Renal Masses | 2.8 | 12 | Citations (PDF) |
| 66 | Preoperative frailty predicts adverse short‐term postoperative outcomes in patients treated with radical nephroureterectomy | 1.5 | 23 | Citations (PDF) |
| 67 | Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score‐matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group | 3.2 | 63 | Citations (PDF) |
| 68 | Comparison of renal functional outcomes of active surveillance and partial nephrectomy in the management of oncocytoma | 2.2 | 17 | Citations (PDF) |
| 69 | The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial | 5.5 | 12 | Citations (PDF) |
| 70 | Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas | 1.7 | 2 | Citations (PDF) |
| 71 | Chronic Kidney Disease After Partial Nephrectomy in Patients With Preoperative Inconspicuous Renal Function – Curiosity or Relevant Issue? | 2.3 | 20 | Citations (PDF) |
| 72 | Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project) | 0.9 | 22 | Citations (PDF) |
| 73 | Outcomes of minimally invasive partial nephrectomy among very elderly patients: report from the RESURGE collaborative international database | 0.5 | 4 | Citations (PDF) |
| 74 | MP35-01 INTERNAL URETHROTOMY AS PRIMARY TREATMENT FOR UNTREATED BULBAR URETHRAL STRICTURES | 4.2 | 0 | Citations (PDF) |
| 75 | On‐clamp versus off‐clamp partial nephrectomy: Propensity score‐matched comparison of long‐term functional outcomes | 1.7 | 56 | Citations (PDF) |
| 76 | SP236THE RADICAL NEPHRECTOMY PARADOX: THE UNEXPECTED AKI'S RISK | 0.8 | 0 | Citations (PDF) |
| 77 | SP267RENAL HISTOLOGY VERSUS ESTIMATED GLOMERULAR FILTRATION RATE: BEYOND THE LOOKING GLASS | 0.8 | 0 | Citations (PDF) |
| 78 | The critical role of lymph node dissection in selecting high-risk nonmetastatic renal cancer candidates for adjuvant therapy after nephrectomy | 1.8 | 11 | Citations (PDF) |
| 79 | Should partial nephrectomy be considered “elective” in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomy | 2.2 | 17 | Citations (PDF) |
| 80 | PS-06-002 Preoperative erectile dysfunction is a proxy of chronic kidney disease after surgery for renal cell carcinoma - a pilot study | 0.5 | 0 | Citations (PDF) |
| 81 | Outcomes of Partial and Radical Nephrectomy in Octogenarians – A Multicenter International Study (Resurge) | 1.4 | 12 | Citations (PDF) |
| 82 | The ERUS Curriculum for Robot-assisted Partial Nephrectomy: Structure Definition and Pilot Clinical Validation | 2.1 | 90 | Citations (PDF) |
| 83 | Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy | 2.3 | 15 | Citations (PDF) |
| 84 | Contemporary National Assessment of Robot-Assisted Surgery Rates and Total Hospital Charges for Major Surgical Uro-Oncological Procedures in the United States | 2.8 | 56 | Citations (PDF) |
| 85 | Postoperative complications increase the risk of long‐term chronic kidney disease after nephron‐sparing surgery in patients with renal cancer and normal preoperative renal function | 3.2 | 4 | Citations (PDF) |
| 86 | Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group) | 2.2 | 52 | Citations (PDF) |
| 87 | Individualised Indications for Cytoreductive Nephrectomy: Which Criteria Define the Optimal Candidates? | 5.8 | 58 | Citations (PDF) |
| 88 | Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the
RECOR
d 2 project) | 3.2 | 28 | Citations (PDF) |
| 89 | Evolution of Robot-assisted Partial Nephrectomy: Techniques and Outcomes from the Transatlantic Robotic Nephron-sparing Surgery Study Group | 2.1 | 54 | Citations (PDF) |
| 90 | Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis | 2.1 | 114 | Citations (PDF) |
| 91 | The Learning Curve for Robot-assisted Partial Nephrectomy: Impact of Surgical Experience on Perioperative Outcomes | 2.1 | 155 | Citations (PDF) |
| 92 | Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project) | 2.2 | 28 | Citations (PDF) |
| 93 | Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: results from three high-volume robotic surgery institutions | 2.1 | 30 | Citations (PDF) |
| 94 | Re: Intradetrusor Injections of Botulinum Toxin A in Adults with Spinal Dysraphism | 4.2 | 0 | Citations (PDF) |
| 95 | External beam radiotherapy with or without androgen deprivation therapy in elderly patients with high metastatic risk prostate cancer | 1.8 | 8 | Citations (PDF) |
| 96 | Risk Based Surveillance after Surgical Treatment of Renal Cell Carcinoma | 4.2 | 14 | Citations (PDF) |
| 97 | Metachronous metastasis of renal cell carcinoma to the urinary bladder: a case report | 3.0 | 7 | Citations (PDF) |
| 98 | Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis | 4.2 | 57 | Citations (PDF) |
| 99 | Conversion of Robot-assisted Partial Nephrectomy to Radical Nephrectomy: A Prospective Multi-institutional Study | 1.4 | 24 | Citations (PDF) |
| 100 | Comparison of functional outcomes of robotic and open partial nephrectomy in patients with pre-existing chronic kidney disease: a multicenter study | 2.2 | 11 | Citations (PDF) |
| 101 | Uterine artery Doppler pulsatility index at 11–38 weeks in ICSI pregnancies with egg donation | 1.2 | 21 | Citations (PDF) |
| 102 | Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer | 3.5 | 8 | Citations (PDF) |
| 103 | ‘Trifecta’ outcomes of robot‐assisted partial nephrectomy in solitary kidney: a Vattikuti Collective Quality Initiative (VCQI) database analysis | 3.2 | 35 | Citations (PDF) |
| 104 | Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium | 2.1 | 38 | Citations (PDF) |
| 105 | Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group) | 2.1 | 134 | Citations (PDF) |
| 106 | A Novel Approach for Apical Dissection During Robot-assisted Radical Prostatectomy: The “Collar” Technique | 3.5 | 38 | Citations (PDF) |
| 107 | Pathological High-risk Renal Cell Carcinoma: Trends in Clinical Characteristics Over 25 Years | 1.1 | 7 | Citations (PDF) |
| 108 | The Effect of Anatomical Location of Lymph Node Metastases on Cancer Specific Survival in Patients with Clear Cell Renal Cell Carcinoma | 1.5 | 13 | Citations (PDF) |
| 109 | Assessing perioperative, functional and oncological outcomes of patients with imperative versus elective indications for robot‐assisted partial nephrectomy: Results from a high‐volume center | 1.7 | 9 | Citations (PDF) |
| 110 | Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma | 2.1 | 100 | Citations (PDF) |
| 111 | Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of Morbidity, Renal Function, and Oncologic Outcomes | 5.8 | 48 | Citations (PDF) |
| 112 | Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma | 2.2 | 6 | Citations (PDF) |
| 113 | The side and the location of the primary tumor does not affect the probability of lymph node invasion in patients with renal cell carcinoma | 2.2 | 8 | Citations (PDF) |
| 114 | Correlation Between Primary Hypospadias Repair and Subsequent Urethral Strictures in a Series of 408 Adult Patients | 3.5 | 23 | Citations (PDF) |
| 115 | Prediction of Competing Mortality for Decision-making Between Surgery or Observation in Elderly Patients With T1 Kidney Cancer | 1.4 | 12 | Citations (PDF) |
| 116 | Long-term survival of patients aged 80 years or older treated with radical prostatectomy for prostate cancer | 0.9 | 12 | Citations (PDF) |
| 117 | When to Perform Preoperative Bone Scintigraphy for Kidney Cancer Staging | 1.4 | 6 | Citations (PDF) |
| 118 | European temporal trends in the use of lymph node dissection in patients with renal cancer | 0.9 | 22 | Citations (PDF) |
| 119 | Lymph node dissection should not be dismissed in case of localized renal cell carcinoma in the presence of larger diseases | 1.8 | 13 | Citations (PDF) |
| 120 | When to perform preoperative chest computed tomography for renal cancer staging | 3.2 | 18 | Citations (PDF) |
| 121 | Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer | 0.9 | 32 | Citations (PDF) |
| 122 | Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions | 2.1 | 83 | Citations (PDF) |
| 123 | Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy | 12.6 | 21 | Citations (PDF) |
| 124 | The Authors Respond | 12.6 | 0 | Citations (PDF) |
| 125 | Impact of stage migration and practice changes on high‐risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades | 3.2 | 30 | Citations (PDF) |
| 126 | Population‐based assessment of cancer‐specific mortality after local tumour ablation or observation for kidney cancer: a competing risks analysis | 3.2 | 17 | Citations (PDF) |
| 127 | End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline | 2.1 | 56 | Citations (PDF) |
| 128 | Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma | 4.2 | 58 | Citations (PDF) |
| 129 | Against the Role of Inflammatory Markers in Renal Cell Carcinoma Prognosis: The Missing Link Between Evidence of Association and Clinical Applicability | 3.5 | 2 | Citations (PDF) |
| 130 | Survival After Conservative Management Versus External Beam Radiation Therapy in Elderly Patients With Localized Prostate Cancer | 1.5 | 23 | Citations (PDF) |
| 131 | MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma | 5.5 | 34 | Citations (PDF) |
| 132 | Lymph node dissection for renal cell carcinoma | 2.0 | 12 | Citations (PDF) |
| 133 | Low Other Cause Mortality Rates Reflect Good Patient Selection in Patients with Prostate Cancer Treated with Radical Prostatectomy | 4.2 | 18 | Citations (PDF) |
| 134 | Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma | 2.2 | 24 | Citations (PDF) |
| 135 | Sociodemographic Disparities in the Nonoperative Management of Small Renal Masses | 2.3 | 8 | Citations (PDF) |
| 136 | Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based Study | 2.1 | 19 | Citations (PDF) |
| 137 | Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer | 1.8 | 15 | Citations (PDF) |
| 138 | The Surgical Learning Curve for One-stage Anterior Urethroplasty: A Prospective Single-surgeon Study | 2.1 | 60 | Citations (PDF) |
| 139 | Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: A Population-based Study | 1.4 | 16 | Citations (PDF) |
| 140 | Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models | 2.1 | 16 | Citations (PDF) |
| 141 | Prediction of Complications Following Partial Nephrectomy: Implications for Ablative Techniques Candidates | 2.1 | 59 | Citations (PDF) |
| 142 | The Impact of Insurance Status on Tumor Characteristics and Treatment Selection in Contemporary Patients With Prostate Cancer | 12.6 | 19 | Citations (PDF) |
| 143 | Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms | 3.2 | 4 | Citations (PDF) |
| 144 | Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer | 0.9 | 38 | Citations (PDF) |
| 145 | Clinical performance of serum isoform [‐2]pro
PSA
(
p2PSA
), and its derivatives %
p2PSA
and the Prostate Health Index, in men aged <60 years: results from a multicentric
E
uropean study | 3.2 | 35 | Citations (PDF) |
| 146 | Clinical performance of the Prostate Health Index (
PHI
) for the prediction of prostate cancer in obese men: data from the
PROMEtheuS
project, a multicentre
E
uropean prospective study | 3.2 | 26 | Citations (PDF) |
| 147 | Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study | 2.1 | 78 | Citations (PDF) |
| 148 | Reply | 1.4 | 0 | Citations (PDF) |
| 149 | BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS) | 2.2 | 11 | Citations (PDF) |
| 150 | Patterns of use and patient characteristics: brachytherapy for localized prostate cancer in octo- and nonagenarians | 2.2 | 4 | Citations (PDF) |
| 151 | Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) | 1.4 | 45 | Citations (PDF) |
| 152 | Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomy | 0.9 | 14 | Citations (PDF) |
| 153 | Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: Results from the North-American case-control study Prostate Cancer & Environment Study | 1.8 | 46 | Citations (PDF) |
| 154 | Minimally Invasive Partial Nephrectomy Versus Laparoscopic Cryoablation for Patients Newly Diagnosed with a Single Small Renal Mass | 3.5 | 13 | Citations (PDF) |
| 155 | Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses | 1.8 | 50 | Citations (PDF) |
| 156 | Identifying Optimal Candidates for Local Treatment of the Primary Tumor Among Patients Diagnosed with Metastatic Prostate Cancer: A SEER-based Study | 2.1 | 143 | Citations (PDF) |
| 157 | Robot-assisted, Single-site, Dismembered Pyeloplasty for Ureteropelvic Junction Obstruction with the New da Vinci Platform: A Stage 2a Study | 2.1 | 49 | Citations (PDF) |
| 158 | Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion | 2.2 | 24 | Citations (PDF) |
| 159 | Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case–control study | 2.2 | 21 | Citations (PDF) |
| 160 | Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma | 2.2 | 31 | Citations (PDF) |
| 161 | Optimal first-line and second-line treatments for metastatic renal cell carcinoma: current evidence | 3.0 | 30 | Citations (PDF) |
| 162 | PISCES: A Horoscope for First-Line Targeted Therapy of Metastatic Renal Cell Carcinoma | 16.9 | 6 | Citations (PDF) |
| 163 | Contemporary 90-day mortality rates after radical cystectomy in the elderly | 0.9 | 99 | Citations (PDF) |
| 164 | Bladder Cancer and Urothelial Impairment: The Role of TRPV1 as Potential Drug Target | 6.4 | 31 | Citations (PDF) |
| 165 | Indication for and Extension of Pelvic Lymph Node Dissection During Robot-assisted Radical Prostatectomy: An Analysis of Five European Institutions | 2.1 | 52 | Citations (PDF) |
| 166 | Multicenter European External Validation of a Prostate Health Index–based Nomogram for Predicting Prostate Cancer at Extended Biopsy | 2.1 | 80 | Citations (PDF) |
| 167 | Long-Term Followup and Deterioration Rate of Anterior Substitution Urethroplasty | 4.2 | 134 | Citations (PDF) |
| 168 | Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination | 1.4 | 40 | Citations (PDF) |
| 169 | Prediction of Early and Late Complications after Oral Mucosal Graft Harvesting: Multivariable Analysis from a Cohort of 553 Consecutive Patients | 4.2 | 69 | Citations (PDF) |
| 170 | Radical prostatectomy represents an effective treatment in patients with specimen‐confined high pathological
G
leason score prostate cancer | 3.2 | 27 | Citations (PDF) |
| 171 | Urethral Lift for Benign Prostatic Hyperplasia: A Comprehensive Review of the Literature | 2.4 | 16 | Citations (PDF) |
| 172 | Clinical performance of serum prostate‐specific antigen isoform [‐2]
proPSA
(
p2PSA
) and its derivatives, %
p2PSA
and the prostate health index (
PHI
), in men with a family history of prostate cancer: results from a multicentre
E
uropean study, the
PROMEtheuS
project | 3.2 | 102 | Citations (PDF) |
| 173 | Complications and Quality of Life After Template-assisted Transperineal Prostate Biopsy in Patients Eligible for Focal Therapy | 1.4 | 37 | Citations (PDF) |
| 174 | Head-to-Head Comparison of Prostate Health Index and Urinary PCA3 for Predicting Cancer at Initial or Repeat Biopsy | 4.2 | 94 | Citations (PDF) |
| 175 | Ventral Oral Mucosal Onlay Graft Urethroplasty in Nontraumatic Bulbar Urethral Strictures: Surgical Technique and Multivariable Analysis of Results in 214 Patients | 2.1 | 80 | Citations (PDF) |
| 176 | Focal Therapy and Prostate Cancer | 0.6 | 0 | Citations (PDF) |
| 177 | Serum Index Test %[-2]proPSA and Prostate Health Index are More Accurate than Prostate Specific Antigen and %fPSA in Predicting a Positive Repeat Prostate Biopsy | 4.2 | 60 | Citations (PDF) |
| 178 | Development and Internal Validation of a Prostate Health Index Based Nomogram for Predicting Prostate Cancer at Extended Biopsy | 4.2 | 54 | Citations (PDF) |
| 179 | The relationship between continence and perineal body tone before and after radical prostatectomy: A pilot study | 1.7 | 13 | Citations (PDF) |
| 180 | Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer | 2.1 | 114 | Citations (PDF) |
| 181 | Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores | 2.1 | 711 | Citations (PDF) |
| 182 | Feasibility and Preliminary Clinical Outcomes of Robotic Laparoendoscopic Single-Site (R-LESS) Pyeloplasty Using a New Single-Port Platform | 2.1 | 77 | Citations (PDF) |
| 183 | Robotic assisted radical prostatectomy in morbidly obese patients: how to create a cost-effective adequate optical trocar | 2.1 | 2 | Citations (PDF) |
| 184 | Robot-Assisted Uretero-Ureterostomy for Iatrogenic Lumbar and Iliac Ureteral Stricture: Technical Details and Preliminary Clinical Results | 2.1 | 31 | Citations (PDF) |
| 185 | Predicting the Risk of Progression in Patients With Kidney Cancer: Aiming at the Optimal Tool in the Optimal Setting | 16.9 | 2 | Citations (PDF) |
| 186 | Recurrent pregnancy loss: a male crucial factor—A systematic review and meta‐analysis | 3.1 | 23 | Citations (PDF) |
| 187 | Re: Alessandro Parente, Kevin Verhoeff, Yanbo Wang, et al. Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma: An International Multicenter Study: Considerations for Further Research. Eur Urol Focus 2025;11:118–25 | 3.5 | 0 | Citations (PDF) |
| 188 | Abstract 7507: Genomic evolution and heterogeneity of von Hippel-Lindau (VHL)-associated clear cell renal cell carcinoma revealed by multi-region whole-genome sequencing | 3.8 | 0 | Citations (PDF) |
| 189 | Interpreting Matched Analyses of Partial Versus Radical Nephrectomy for cT2 Tumors: Methodological Caveats and Clinical Implications | 4.2 | 0 | Citations (PDF) |
